• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: September 24-28, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

September 24-28, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/24/12Washington, DCN/AN/AFriends of Cancer Research Awards Ceremony
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/25/12Washington, DCN/AN/APresident's Council of Advisors on Science and Technology (PCAST) "FDA Perspective and Implementation Actions" at National Academy of Sciences
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/27/12New York, NYN/AN/A2nd Annual Concordia Summit
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs9/28/12Washington, DCN/AN/APartnership for Safe Medicines Interchange at National Press Club
John M. Taylor, III, J.D., Counselor to the Commissioner9/25/12Cincinnati, OHSeveral FDA staff and officialsSeveral representatives from Xavier Speech at FDA/Xavier Conference 
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products9/24/12-9/28/12 N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Chief Counsel9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine9/28/12Arlington, VAN/AN/ASpeech at 2nd Annual Potomac Regional Veterinary Conference
Jesse Goodman, M.D., M.P.H., Chief Scientist9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Walter Harris, Chief Operating Officer9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Jeanne Ireland, Associate Commissioner for Legislation9/25/12Washington, DCJane Alelrad, Geba Gregory, Keith Webber and Julia TierneyKeith Flanagan, Grace Stuntz (Senate Health, Education, Labor & Pensions Committee Minority Staff); Hayden Rhudy (Senator Orrin Hatch [R-UT]); Erin Katzelnick-Wise (Representative Anna Eshoo [D-CA]); Clay Alspach (House Committee on Energy and Commerce, Majority Staff); Josh Teitelbaum (Senator Kay Hagan [D-NC)]); Kim Trzeciak (Representative John Dingell [D-MI]) FDA's Policy Towards Approving Complex Drugs Through the 505(j) Pathway
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition9/25/12College Park, MDLinda Tollefson, Sherri Dennis,  Susan Fitzpatrick, Tracey Summers, Lori Papadakis, Steve BradbardTracy Lang, Tracey Cowen, David Bottimore (Vesar & Consultants)Chemical Safety Review Questions
Peter Lurie, Acting Associate Commissioner for Policy and Planning9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco9/24/12Silver Spring, MDN/AN/AFDA OOPD Pediatric Medical Devices Workshop
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco9/25/12Silver Spring, MDN/AJoe Panetta, Jimmy Jackson (BIOCOM)FDA Survey Related Activities
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods9/28/12Silver Spring, MDCamille Brewer, Mary Lou Valdez, Steven Solomon, Roberta Wagner, Dan McChesny, Leslie Ball, Bernadette Dunham, Christopher Hickey, Mike Landa, Nega Beru, Jeff Read, Erika Armani, Patrick Bowen, Domenic Veneziano, Lisa Romano, Susan Brecher, Cory BryantVice Minister Pu Changcheng, Du Yuejun (General Administration of Quality Supervision, Inspection, Quarantine);  Kong Xiaokang, Li Yuchao (Department of International Cooperation); Bi Kexin, Wang Ning (Import-Export Safety Bureau); Zhou Shenghe (Chinese Embassy); Wang Xinwu (Department for Supervision on Animal and Plant Quarantine); Huang Bin (Department of Registration)China Administration of Quality Supervision, Inspection and Quarantine Bilateral 
Mary Lou Valdez, Associate Commissioner for International Programs9/27/12Washington, DCSeveral FDA officials and staff membersSeveral representatives from the local diplomatic communityEmbassy Briefing entitled “Navigating FDA’s Website:  Hands-on Training for the Diplomatic Community”
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs9/24/12-9/28/12N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research9/24/12-9/28/12N/AN/AN/ANo Significant Meetings